Sector consensus Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 08/07/2025			5-day change	1st Jan Change
175,500.00 ^KRW	-1.85%		+9.96%	-2.66%

07-04	Celltrion Holdings to Buy KRW500 Billion in Celltrion Shares, Eyes Portfolio Expansion	MT
06-26	Tranche Update on Celltrion, Inc.'s Equity Buyback Plan announced on May 20, 2025.	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
CELLTRION, INC.	₩215,152.97	+20.33%	22
LONZA GROUP AG	CHF 658.11	+17.94%	22
BEONE MEDICINES LTD.	US$330.95	+37.33%	23
IQVIA HOLDINGS INC.	US$189.65	+16.75%	19
EUROFINS SCIENTIFIC SE	€59.73	-0.91%	14
ICON PUBLIC LIMITED COMPANY	US$175.2	+18.71%	15
ASCENDIS PHARMA A/S	US$195.94	+30.64%	16
QIAGEN N.V.	US$50.35	+5.94%	15
TEMPUS AI, INC.	US$66.7	+14.98%	10
MEDPACE HOLDINGS, INC.	US$300.2	-5.87%	12
BLUEPRINT MEDICINES CORPORATION	US$130.6	+1.71%	15
BIO-TECHNE CORPORATION	US$67.28	+30.55%	13
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	US$156.14	+1.46%	17
REVOLUTION MEDICINES, INC.	US$72.91	+98.82%	11
IONIS PHARMACEUTICALS, INC.	US$57.89	+38.55%	26
HANGZHOU TIGERMED CONSULTING CO., LTD	CN¥53.6	+1.16%	13
PHARMARON BEIJING CO., LTD.	CN¥29.91	+24.94%	11
BACHEM HOLDING AG	CHF 71	+24.56%	8
Average	12,101.06	+20.98%	16
Weighted average by Cap.	24,699.29	+20.41%	18